Mina L Xu
Yale University
H-index: 25
North America-United States
Top articles of Mina L Xu
Liquid biopsy‐based circulating tumour (ct) DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results
Histopathology
2024/2/29
Vignesh Shanmugam
H-Index: 7
Mina L Xu
H-Index: 14
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
The Journal of clinical investigation
2024/2/1
Genetics and pathologic landscape of lineage switch of acute leukemia during therapy
Blood cancer journal
2024/1/25
Spatially Exploring RNA Biology in Archival Formalin-Fixed Paraffin-Embedded Tissues
bioRxiv
2024
Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program
The American Journal of Pathology
2024/1/1
Mina L Xu
H-Index: 14
Acute Epstein–Barr virus infection resembling cutaneous T‐cell lymphoma
Journal of Cutaneous Pathology
2023/3
Catherine Baker
H-Index: 1
Mina L Xu
H-Index: 14
Breast implant‐associated anaplastic large‐cell lymphoma: A series of two case reports diagnosed by cytopathology
Diagnostic Cytopathology
2023/1
Data-Driven Harmonization of 2022 Who and ICC Classifications of Myelodysplastic Syndromes/Neoplasms (MDS): A Study By the International Consortium for MDS (icMDS)
Blood
2023/11/28
Best Practices in CD30 Immunohistochemistry Testing, Interpretation, and Reporting: An Expert Panel Consensus
Archives of Pathology & Laboratory Medicine
2023/1/1
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
Blood advances
2023/5/16
Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series
Clinical Lymphoma Myeloma and Leukemia
2023/11/1
High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq
Nature Biotechnology
2023/10
Updates in classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International …
2023/8/19
S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM …
HemaSphere
2023/8
IRF8 may be a useful marker for blastic plasmacytoid dendritic cell neoplasm, especially with weak CD123 expression
Journal of Cutaneous Pathology
2023/7
Demetrios Braddock
H-Index: 13
Mina L Xu
H-Index: 14
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Blood advances
2023/6/27
Updates in Classification of Myelodysplastic Syndrome
2023/5/1
Mina L Xu
H-Index: 14
EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential
Blood Advances
2023/4/11
T-Cell Prolymphocytic Leukemia With t (X; 14)(q28; q11. 2): A Clinicopathologic Study of 15 Cases
American journal of clinical pathology
2023/4/1
Emerging immunohistochemical biomarkers for myeloid neoplasms
2023/4
Mina L Xu
H-Index: 14